SEPN
Septerna, Inc.
Key Financials
Net Income
$-48879000
↑ 31.9%
Total Assets
$596.2M
↑ 30.6%
Operating Income
$-68297000
↑ 15.5%
Revenue
$46.0M
↑ 4174.5%
EPS (Diluted)
$-1.10
↑ 84.8%
Cash & Equivalents
$120.7M
↓ 49.3%
Total Liabilities
$214.3M
↑ 486.9%
Shareholders' Equity
$381.9M
↓ 9.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 6/16/2026 | View on SEC |
| 144 | 6/12/2026 | View on SEC |
| 4 | 6/3/2026 | View on SEC |
| 4 | 5/28/2026 | View on SEC |
| 144 | 5/26/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| ARS | 4/30/2026 | View on SEC |
| DEFA14A | 4/30/2026 | View on SEC |
| DEF 14A | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SEPN |
| Company Name | Septerna, Inc. |
| CIK | 1984086 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-338-3533 |